1. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
    Liubing Hu et al, 2022, Frontiers in Oncology CrossRef
  2. Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review)
    Amber Xinyu Li et al, 2023, Cancers CrossRef
  3. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
    Masaaki Ito et al, 2022, Esophagus CrossRef
  4. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
    Shu-Yang Li et al, 2023, Frontiers in Cardiovascular Medicine CrossRef